Data from the All India Organisation of Chemists & Druggists (AIOCD) showed that in the June 2020-May 2021 period, Indians bought Rs 1,220 crore of antiviral drug Favipiravir and Rs 833 crore of Remdesivir. Sales of antibiotic Azithromycin stood at Rs 992 crore, 38% higher on-year. Sales of Doxycycline almost tripled to Rs 85 crore. Sales of anti-parasitic drug Ivermectin surged over 10 times to Rs 237 crore.
